While there are hopes for widespread vaccinations in the U.S., the pandemic has shown no signs of slowing. Globally, there are now 102.66 million cases. In the U.S., the count is up to 26 million. In India, it’s up to 10.7 million. In Brazil, 9.1 million. In Russia, 3.8 million. In the UK, 3.8 million. Hospitals have been strained.
In fact, according to the Associated Press, “An Associated Press analysis of federal hospital data shows that since November, the share of U.S. hospitals nearing the breaking point has doubled. More than 40% of Americans now live in areas running out of ICU space, with only 15% of beds still available.” Along the way, it’s increasing the need for testing, which is also seeing incredible demand.
That’s where companies like Datametrex AI Limited (TSXV:DM)(OTC:DTMXF), Laboratory Corp. of America Holdings (NYSE:LH), Abbott Laboratories (NYSE:ABT), Quest Diagnostics Inc. (NYSE:DGX), and Chembio Diagnostics Inc. (NASDAQ:CEMI) are able to help.